|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/107 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/26 | (2006.01) |
| (11) | Number of the document | 3463298 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17805885.5 |
| Date of filing the European patent application | 2017-06-02 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/086942 |
| Date | 2017-06-02 |
| (87) | Number | WO 2017/206940 |
| Date | 2017-12-07 |
| (30) | Number | Date | Country code |
| 201662344660 P | 2016-06-02 | US |
| (72) |
HAO, Wei-Hua , TW
HSUEH, Shu-Piing , TW
HSU, Chang-Shan , TW
|
| (73) |
Innopharmax, Inc. ,
9F., No.22, Lane 478
Rueiguang Rd.
Neihu District, Taipei City 11492,
TW
|
| (54) | METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY |
| METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY |